ESCMID eLibrary
Search results
Icon explanation
Abstract
ePoster
Handout
Image
Journal Article
Presentation
Video
Webcast
-
O1163
Ceftazidime-avibactam population pharmacokinetic (PK) and PK-pharmacodynamic (PK/PD) modelling and simulation to support paediatric dosing
16 April 2019
Session: PK/PD to guide dosing in special populations
Relevance:100% -
O1061
Pharmacodynamics of VNRX-5133 in combination with cefepime studied in an in vitro model of infection
16 April 2019
Session: Defining exposure, efficacy and safety of new antimicrobial agents
Relevance:100% -
O1060
Pharmacokinetics-pharmacodynamics of the novel beta-lactamase inhibitor GT-055 in combination with the siderophore cephalosporin GT-1
16 April 2019
Session: Defining exposure, efficacy and safety of new antimicrobial agents
Relevance:100% -
O1161
Piperacillin population pharmacokinetics in 161 critically ill patients undergoing renal replacement therapy, data from the SMARRT study
16 April 2019
Session: PK/PD to guide dosing in special populations
Relevance:100% -
O1063
WCK-771 (INN: levonadifloxacin): pharmacodynamic index (PDI) and PD target (PDT) determination studies involving methicillin /quinolone-resistant Staphylococcus aureus (MRSA/QRSA) employing neutropenic mouse lung infection model
16 April 2019
Session: Defining exposure, efficacy and safety of new antimicrobial agents
Relevance:100% -
O1160
Determination of optimal dosing and maintenance doses for continuous infusion of vancomycin in critically ill patients: population pharmacokinetic modelling and simulation
16 April 2019
Session: PK/PD to guide dosing in special populations
Relevance:100% -
O1162
Pharmacokinetics of iclaprim by age, weight, race and renal/hepatic function in patients with acute bacterial skin and skin structure infections: phase III REVIVE trials
16 April 2019
Session: PK/PD to guide dosing in special populations
Relevance:100% -
O1064
In vivo pharmacodynamic profile of cefepime in combination with VNRX-5133 against serine beta-lactamase-producing Gram-negative bacteria in the neutropenic murine thigh infection model
16 April 2019
Session: Defining exposure, efficacy and safety of new antimicrobial agents
Relevance:100% -
O1168
Linezolid doses should be lowered in renal impairment to improve safety
16 April 2019
Session: PK/PD to guide dosing in special populations
Relevance:100% -
O1167
Pharmacokinetic and pharmacodynamic target attainment after dose reduction of ciprofloxacin in patients with renal impairment
16 April 2019
Session: PK/PD to guide dosing in special populations
Relevance:100%
Search narrowed by
-
Topics
-
Type of material
- Abstract publication (1102)
- Poster presentation (999)
- ePoster (325)
- PGEC lecture (225)
- Oral presentation (197)
- ePoster presentation (158)
- Symposium lecture (115)
- Conference lecture (67)
- Workshop lecture (46)
- PGTW lecture (23)
- Summer School lecture (15)
- 2-Hour Symposium (10)
- 1-Hour Symposium (9)
- Meet-the-Expert lecture (9)
- 2-Hour Educational Workshop (7)
- Educational Course lecture (3)
- Keynote Lecture (3)
- Original Article (1)
-
Time period
